Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q3 2025 · 10-Q
Revenue—
Net Income-$3.07M-$3.07MN/M vs Q3 2024 EPS Diluted-$1.96-$1.96N/M vs Q3 2024 Operating Income-$3,123,773N/M Operating Cash Flowderived-$2,984,515N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 7, 2025 · 38 d after period end